|
|
||||||||
Cutting Edge |








,¶
* Department of Oncogenesis, Graduate School of Medicine,
Faculty of Medicine, School of Allied Health Sciences,
Department of Oncogene Research, Research Institute for Microbial Diseases,
Division of Molecular Genetics, Institute for Molecular and Cellular Biology, Osaka University, Osaka, Japan; and
¶ Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Saitama, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although Cbp/PAG thus functions as a negative regulator of the Src family PTKs by its interaction with Csk, phosphorylation of Cbp/PAG itself could be controlled by the Src family PTKs (6, 7). Coexpression of c-Src and Cbp in 293T cells resulted in Cbp phosphorylation. PAG served as a substrate for Lck and Fyn, but not for ZAP-70 and/or Syk in COS cells expressing PAG and various PTKs; and selective inhibitors for the Src family PTKs, PP1 and PP2, suppressed Cbp/PAG phosphorylation both in vivo and in vitro. However, it remains unknown which kinase, Lck or Fyn, is involved in physiological regulation for Cbp phosphorylation in T cells. Moreover, a molecular mechanism for activation and inactivation of the Src family PTKs in lipid rafts in TCR signaling is also still elusive. In this study, we demonstrated that Fyn, but not Lck, has a high catalytic activity in rafts and is responsible for Cbp phosphorylation in T cells at the resting stage. Our results clearly demonstrate that Fyn is critical for Cbp-Csk interaction in proximal TCR signaling.
| Materials and Methods |
|---|
|
|
|---|
The Fyn-/- mice were generated as previously described (10). The heterozygous Fyn+/- mice were back-crossed with C57BL/6 mice for six generations, and the B6-Fyn+/- mice were then intercrossed to produce homozygous Fyn-/- B6 mice. Mice were analyzed for the fyn gene genotype by PCR (data not shown).
Abs and reagents
The following Abs were used: MOL 171 (11),
anti-Lck mAb; OKT3 (American Type Culture Collection, Manassas,
VA), anti-human CD3
mAb; anti-Cbp and anti-Csk
polyclonal Abs (6); antitransferrin receptor mAb (Zymed
Laboratories, San Francisco, CA); anti-Fyn mAb (Santa Cruz
Biotechnology, Santa Cruz, CA); anti-Lck Ab (Upstate Biotechnology,
Lake Placid, NY); anti-phospho-Lck (Tyr505)
Ab (Cell Signaling Technology, Beverly, MA); PY20,
anti-phosphotyrosine mAb (Transduction Laboratories, Lexington,
KY); and goat anti-hamster IgG (Cappel, Aurora, OH). Dye-labeled
Abs used for flow cytometry were purchased from BD PharMingen (San
Diego, CA). Cholera toxin B-HRP, enolase, and a random polymer
of glutamate and tyrosine (poly EY) were purchased from Sigma-Aldrich
(St. Louis, MO).
Isolation of a raft fraction, immunoprecipitation, and immunoblotting analysis
Isolation of a raft fraction, immunoprecipitation, and immunoblotting analysis were performed as previously described (11).
In vitro kinase assays
Lck or Fyn immunoprecipitates (IPs) were washed twice
with washing buffer (MES-buffered saline (25 mM MES (pH 6.5), 150 mM
NaCl) with 0.1% Triton X (TX)-100) and twice with kinase buffer
(KB; 50 mM HEPES (pH 7.4), 10 mM MgCl2, 5 mM
MnCl2, and 0.5 mM sodium orthovanadate). The IPs
suspended in KB with 1 µg of acid-denatured enolase and 10 µCi
[
-32P]ATP were incubated at 30°C for 15
min and stopped by addition of 5x SDS-PAGE sample buffer. The enolase
and IPs were separated by SDS-PAGE and detected by autoradiography. The
relative amount of Lck or Fyn present in each sample was detected by
immunoblotting. The kinase activity of Csk was measured by
[32P]O4 labeling of poly EY as a substrate. Cbp
IPs was suspended in KB with 4 µg of poly EY and 10 µCi
[
-32P]ATP. To block Cbp-Csk interaction,
Cbp-4 (ISAMYSSVNK) or Cbp-2 (EDCLYETVKE) phosphopeptides were added to
cell lysates before immunoprecipitation with anti-Cbp Abs as
previously described (12). The activity was visualized and
quantified using a BAS-1500 Bioimage Analyzer (Fuji Photo Film, Tokyo,
Japan).
| Results |
|---|
|
|
|---|
To investigate the localization of Lck and Fyn kinase activities
in T cells, we isolated the raft fraction from Jurkat cells using a
sucrose gradient. Successful fractionation was confirmed by the
localization of a raft and a nonraft marker, GM1, and transferrin
receptor, respectively (Fig. 1
A). In vitro kinase assays
were performed using Lck or Fyn immunoprecipitated from the raft and
the nonraft fractions. The kinase activity was measured by
[32P]O4 labeling of enolase, a specific
substrate for the Src family kinases, and the amount of Lck or Fyn
present in each fraction was measured by immunoblotting (Fig. 1
B). Intriguingly, although the amount of Lck was highly
concentrated in the raft fraction, Lck kinase activity was
predominantly detected in the nonraft fraction. This is
consistent with previous findings by Rodgers and Rose
(13). TCR stimulation did not increase Lck kinase activity
nor change its localization among the fractions. In contrast to Lck,
Fyn kinase activity was highly enriched in the raft fraction before and
after TCR stimulation. The differential localization of Lck and Fyn was
not changed at the later time point, although the activities per se
were decreased 60 min after TCR cross-linking (data not shown).
|
Together, in contrast to the low activity of Lck, Fyn has a catalytic activity in rafts both in Jurkat and normal T cells even before T cell activation. Successful detection for Fyn kinase activity using the raft fraction effectively eliminates the possibility that lack of Lck kinase activity in the raft fraction was due to general disruption of enzymatic activity in this fraction caused by equilibrium density gradient centrifugation.
Fyn is essential for Cbp/PAG phosphorylation in resting T cells
The substantial kinase activity of Fyn in rafts from Jurkat,
thymocytes, and peripheral T cells before activation prompted us to
examine a specific role for this kinase in raft-mediated T cell
activation. Recently, a new adaptor molecule, Cbp, which exerts an
important function in Src family PTK signaling pathways, has been
identified. Upon phosphorylation, Cbp, which is
constitutively localized in rafts, can recruit Csk to rafts. We next
investigated which kinase is responsible for Cbp
phosphorylation in T cell membranes. Because
raft-associated Fyn, but not Lck, had a catalytic activity in T cells
before activation, we speculated that Cbp is phosphorylated
by Fyn in resting T cells. To address this point, we used T cells from
Fyn-/- mice. The
phosphorylation level of Cbp was investigated using
thymocytes and peripheral T cells from Fyn-/-
mice. As shown in Fig. 2
, A
and B, Cbp phosphorylation was greatly
reduced in T cells from Fyn-/- mice. In three
independent experiments, the levels of Cbp
phosphorylation in peripheral T cells and thymocytes
from Fyn-/- mice were reduced to 12 and 18%,
respectively, compared with those from normal mice. In contrast, Cbp
expression was comparable between T cells from normal and
Fyn-/- mice, although the level of Cbp
expression seemed to vary in T cells from individual
Fyn-/- mice. Because Cbp
phosphorylation was not completely inhibited in
Fyn-/- T cells, it is likely that kinases other
than Fyn are also involved in Cbp phosphorylation.
Nonetheless, the results using Fyn-/- T cells
clearly demonstrated that Fyn is predominantly responsible for the
phosphorylation of Cbp in resting T cells.
|
We next investigated whether decreased Cbp
phosphorylation may alter Cbp-Csk interaction and Csk
activity in Fyn-/- T cells. Thymocytes and
peripheral T cells from normal and Fyn-/- mice
were solubilized with lysis buffer containing
n-octyl-
-D-glucoside,
immunoprecipitated with anti-Cbp, and immunoblotted with
anti-Csk. The amounts of Csk associated with Cbp in thymocytes and
peripheral T cells from Fyn-/- mice were
decreased to 29 and 31%, respectively, of those from normal mice on
the average from three experiments (Fig. 3
A). To determine whether this
reduction in Cbp-Csk interaction resulted in a decrease in Csk
activity, we examined Csk activity in in vitro kinase assays using poly
EY as substrate. As shown in Fig. 3
B, Cbp IPs from normal
thymocytes were capable of phosphorylating poly EY efficiently, and
this phosphorylation was almost completely blocked by
the addition of Cbp-4 phosphopeptide which contains
Tyr314 and is known to compete with Cbp-Csk
interaction (12). Another phosphopeptide, Cbp-2, which
cannot interfere with the binding of Cbp to Csk was not able to inhibit
the phosphorylation of poly EY. These results clearly
demonstrate that the phosphorylation of poly EY in Cbp
IPs was specifically attributable to the kinase activity of Csk. The
kinase activity of Cbp-associated Csk in Fyn-/-
thymocytes was decreased to 50% of that from normal thymocytes (Fig. 3
B, lines 1 and 4). We observed a
similar inhibition of Csk activity in Fyn-/-
peripheral T cells (data not shown). Thus, the inhibition of Cbp
phosphorylation in Fyn-/- T
cells impaired Cbp-Csk interaction and the kinase activity of
Csk.
|
The kinase activity of Lck is negatively regulated by
phosphorylation of a C-terminal residue
(Tyr505 in Lck) by Csk. We next analyzed the
phosphorylation level of Lck
Tyr505 in Fyn-/- T cells
using a phosphospecific Ab to Tyr505 of Lck. We
especially focused on Lck Tyr505
phosphorylation in the raft fraction because we have
observed that phosphorylation of
Tyr505 was predominantly detected in the raft
fraction (data not shown). Although the amount of Lck was comparable
between normal and Fyn-/- thymocytes,
Tyr505 phosphorylation in the
raft fraction was clearly decreased in Fyn-/-
thymocytes (Fig. 3
C). This result indicates that Fyn
promotes phosphorylation of the negative regulatory
tyrosine of Lck by way of phosphorylating Cbp and recruiting Csk in
lipid rafts.
Naive phenotype T cells decrease in Fyn-/- mice
Because the data presented above demonstrated that Fyn regulates
Cbp-Csk interaction and Csk activity in resting T cells, we next asked
whether this regulation influences the maintenance of naive T cells.
Naive and memory T cells can be defined by the expression of surface
markers, CD44 and CD62 ligand (CD62L; L-selectin; Ref.
14). As shown in Fig. 4
, naive CD44lowCD62Lhigh T
cells were substantially reduced in both the CD4+
and CD8+ T cell populations from
Fyn-/- mice compared with those from normal
mice. This result suggests that the regulation of Cbp-Csk interaction
by Fyn is important for keeping peripheral T cells in a resting state
in vivo.
|
| Discussion |
|---|
|
|
|---|
Although Lck and Fyn are expressed at a similar level in mature T cells (17), a unique function for each PTK is not as yet well clarified. However, Fyn is known to be overexpressed in CD4-CD8- T cells from MRL/lpr mice that have an abnormal proliferative capacity and exhibit altered TCR signal transduction pathways (18). Moreover, increased Fyn kinase activity was shown to correlate with maintenance of the anergic state in T cells (19). Given that Fyn regulates an activation threshold of T cells through controlling Cbp-Csk interaction, it is possible that Csk-mediated regulation of TCR signaling could be impaired in MRL/lpr T cells or anergic T cells. Further investigation of the molecular interaction between Cbp and tyrosine kinases will provide important insights not only into physiological regulation of TCR signaling in lipid rafts but into altered T cell function in immunological diseases.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 K.Y. and M.N. contributed equally to this work. ![]()
3 Address correspondence and reprint requests to Dr. Atsushi Kosugi, Faculty of Medicine, School of Allied Health Science, Osaka University, 1-7, Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail address: kosugi{at}sahs.med.osaka-u.ac.jp ![]()
4 Abbreviations used in this paper: PTK, protein tyrosine kinase; Cbp, Csk-binding protein; PAG, phosphoprotein associated with glycolipid-enriched microdomains; TX, Triton X; poly EY, polymer of glutamate and tyrosine; IP, immunoprecipitate; KB, kinase buffer; CD62L, CD62 ligand. ![]()
Received for publication May 6, 2002. Accepted for publication July 19, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Chen, L. Veracini, C. Benistant, and K. Jacobson The transmembrane protein CBP plays a role in transiently anchoring small clusters of Thy-1, a GPI-anchored protein, to the cytoskeleton J. Cell Sci., November 1, 2009; 122(21): 3966 - 3972. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vacaresse, B. Moller, E. M. Danielsen, M. Okada, and J. Sap Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTP{alpha} Is Substrate-specific and Compatible with Lipid Raft Localization J. Biol. Chem., December 19, 2008; 283(51): 35815 - 35824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Mamchak, B. M. Sullivan, B. Hou, L. M. Lee, J. K. Gilden, M. F. Krummel, R. M. Locksley, and A. L. DeFranco Normal Development and Activation but Altered Cytokine Production of Fyn-Deficient CD4+ T Cells J. Immunol., October 15, 2008; 181(8): 5374 - 5385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tauzin, H. Ding, K. Khatib, I. Ahmad, D. Burdevet, G. van Echten-Deckert, J. A. Lindquist, B. Schraven, N.-u. Din, B. Borisch, et al. Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts Blood, February 15, 2008; 111(4): 2310 - 2320. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Solheim, K. M. Torgersen, K. Tasken, and T. Berge Regulation of FynT Function by Dual Domain Docking on PAG/Cbp J. Biol. Chem., February 1, 2008; 283(5): 2773 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Morton, B. McManus, P. Garside, A. McI. Mowat, and M. M. Harnett Inverse Rap1 and Phospho-ERK Expression Discriminate the Maintenance Phase of Tolerance and Priming of Antigen-Specific CD4+ T Cells In Vitro and In Vivo J. Immunol., December 15, 2007; 179(12): 8026 - 8034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Filby, B. Seddon, J. Kleczkowska, R. Salmond, P. Tomlinson, M. Smida, J. A. Lindquist, B. Schraven, and R. Zamoyska Fyn Regulates the Duration of TCR Engagement Needed for Commitment to Effector Function J. Immunol., October 1, 2007; 179(7): 4635 - 4644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smida, A. Posevitz-Fejfar, V. Horejsi, B. Schraven, and J. A. Lindquist A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation Blood, July 15, 2007; 110(2): 596 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Davidson, B. Schraven, and A. Veillette PAG-Associated FynT Regulates Calcium Signaling and Promotes Anergy in T Lymphocytes Mol. Cell. Biol., March 1, 2007; 27(5): 1960 - 1973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Mutch, R. Sanyal, T. L. Unruh, L. Grigoriou, M. Zhu, W. Zhang, and J. P. Deans Activation-induced endocytosis of the raft-associated transmembrane adaptor protein LAB/NTAL in B lymphocytes: evidence for a role in internalization of the B cell receptor Int. Immunol., January 1, 2007; 19(1): 19 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kitaura, Y. Kawakami, M. Maeda-Yamamoto, V. Horejsi, and T. Kawakami Dysregulation of Src Family Kinases in Mast Cells from Epilepsy-Resistant ASK versus Epilepsy-Prone EL Mice J. Immunol., January 1, 2007; 178(1): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lovatt, A. Filby, V. Parravicini, G. Werlen, E. Palmer, and R. Zamoyska Lck Regulates the Threshold of Activation in Primary T Cells, While both Lck and Fyn Contribute to the Magnitude of the Extracellular Signal-Related Kinase Response Mol. Cell. Biol., November 15, 2006; 26(22): 8655 - 8665. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingley, J. R. Schneider, C. J. Payne, D. J. McCarthy, K. W. Harder, M. L. Hibbs, and S. P. Klinken Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells J. Biol. Chem., October 20, 2006; 281(42): 31920 - 31929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shirakawa, Y. Wang, S. Tahara-Hanaoka, S.-i. Honda, K. Shibuya, and A. Shibuya LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell Int. Immunol., June 1, 2006; 18(6): 951 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Maksumova, H. T. Le, F. Muratkhodjaev, D. Davidson, A. Veillette, and C. J. Pallen Protein Tyrosine Phosphatase {alpha} Regulates Fyn Activity and Cbp/PAG Phosphorylation in Thymocyte Lipid Rafts J. Immunol., December 15, 2005; 175(12): 7947 - 7956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-W. Dobenecker, C. Schmedt, M. Okada, and A. Tarakhovsky The Ubiquitously Expressed Csk Adaptor Protein Cbp Is Dispensable for Embryogenesis and T-Cell Development and Function Mol. Cell. Biol., December 1, 2005; 25(23): 10533 - 10542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tani-ichi, K. Maruyama, N. Kondo, M. Nagafuku, K. Kabayama, J.-i. Inokuchi, Y. Shimada, Y. Ohno-Iwashita, H. Yagita, S. Kawano, et al. Structure and function of lipid rafts in human activated T cells Int. Immunol., June 1, 2005; 17(6): 749 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shirakawa, K. Shibuya, and A. Shibuya Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226) Int. Immunol., March 1, 2005; 17(3): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Paccani, L. Patrussi, C. Ulivieri, J. L. Masferrer, M. M. D'Elios, and C. T. Baldari Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling Blood, March 1, 2005; 105(5): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugie, M.-S. Jeon, and H. M. Grey Activation of naive CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling PNAS, October 12, 2004; 101(41): 14859 - 14864. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xing, L. T. Donlin, R. H. Miller, and K. Alexandropoulos The Adapter Molecule Sin Regulates T-Cell-Receptor-Mediated Signal Transduction by Modulating Signaling Substrate Availability Mol. Cell. Biol., May 15, 2004; 24(10): 4581 - 4592. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Rybin, J. Guo, A. Sabri, H. Elouardighi, E. Schaefer, and S. F. Steinberg Stimulus-specific Differences in Protein Kinase C{delta} Localization and Activation Mechanisms in Cardiomyocytes J. Biol. Chem., April 30, 2004; 279(18): 19350 - 19361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Filipp, B. L. Leung, J. Zhang, A. Veillette, and M. Julius Enrichment of Lck in Lipid Rafts Regulates Colocalized Fyn Activation and the Initiation of Proximal Signals through TCR{alpha}{beta} J. Immunol., April 1, 2004; 172(7): 4266 - 4274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuoka, S. Nada, and M. Okada Mechanism of Csk-mediated Down-regulation of Src Family Tyrosine Kinases in Epidermal Growth Factor Signaling J. Biol. Chem., February 13, 2004; 279(7): 5975 - 5983. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Criado and J. Madrenas Superantigen Stimulation Reveals the Contribution of Lck to Negative Regulation of T Cell Activation J. Immunol., January 1, 2004; 172(1): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shima, S. Nada, and M. Okada Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts PNAS, December 9, 2003; 100(25): 14897 - 14902. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Latif, T. Ando, S. Daniel, and T. F. Davies Localization and Regulation of Thyrotropin Receptors within Lipid Rafts Endocrinology, November 1, 2003; 144(11): 4725 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thomas, R. Kumar, A. Preda-Pais, S. Casares, and T.-D. Brumeanu A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera J. Immunol., June 15, 2003; 170(12): 5981 - 5992. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vang, H. Abrahamsen, S. Myklebust, V. Horejsi, and K. Tasken Combined Spatial and Enzymatic Regulation of Csk by cAMP and Protein Kinase A Inhibits T Cell Receptor Signaling J. Biol. Chem., May 9, 2003; 278(20): 17597 - 17600. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Filipp, J. Zhang, B. L. Leung, A. Shaw, S. D. Levin, A. Veillette, and M. Julius Regulation of Fyn Through Translocation of Activated Lck into Lipid Rafts J. Exp. Med., May 5, 2003; 197(9): 1221 - 1227. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |